Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Income Quality Over TimeContracting
Percentile Rank23
3Y CAGR+0.8%
5Y CAGR+0.6%
Year-over-Year Change
Quality of reported income
3Y CAGR
+0.8%/yr
vs +69.3%/yr prior
5Y CAGR
+0.6%/yr
Consistent
Acceleration
-68.5pp
Decelerating
Percentile
P23
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.66 | -52.9% |
| 2024 | 1.40 | +43.6% |
| 2023 | 0.97 | +51.5% |
| 2022 | 0.64 | -23.6% |
| 2021 | 0.84 | +31.6% |
| 2020 | 0.64 | -46.4% |
| 2019 | 1.19 | +1424.3% |
| 2018 | 0.08 | -92.6% |
| 2017 | 1.05 | +19.2% |
| 2016 | 0.88 | - |